Mass General Hospital

Harvard Medical School

Navigation

Welcome to the MGH Center for Women’s Mental Health

Welcome

Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH. Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

The National Pregnancy Registry for Psychiatric Medications:

All pregnant women ages 18-45 are eligible to enroll in the registry. The primary goal of this Registry is to determine the frequency of major malformations, such as heart defects, cleft lip, or neural tube defects, in infants exposed to atypical antipsychotics and antidepressants during pregnancy.  We are currently seeking both controls and those being treated with atypical antipsychotics and/ or antidepressants. For more information, please visit this page, call 1-866-961-2388 or e-mail registry@womensmentalhealth.org.

 

Course of ADHD in Pregnancy and the Postpartum

Are you pregnant? Do you have a history of ADHD?

If you are less than 20 weeks pregnant and have a history of ADHD, you may be eligible to take part in an observational research study for women maintaining, decreasing, or discontinuing psychostimulants during pregnancy and the postpartum. Women who participate will have 6 study visits from time of enrollment (<20 weeks pregnant) to 24 weeks postpartum.  The first visit must be in-person at Massachusetts General Hospital with the option to complete the remaining visits in-person or over the phone.

For more information, please call (617)726-2912 or email the study coordinator at onoe@partners.org

 

 

 EnBrace HR for MDD Relapse Prevention in         Women Trying to Conceive and Early Pregnancy:

 

Are you pregnant or planning a pregnancy? Do you feel depressed or have a history of depression? If you are less than 28 weeks pregnant or trying to conceive and have experienced depression now or in the past, you may be eligible to take part in a research study for the treatment of depression with a prenatal supplement. For more information, please visit this page, call Taylor at 617-643-9284 or email tchurch1@partners.org

 

 

Lifestyle Intervention Research Study Opportunity:

Are you pregnant or planning to become pregnant? Do you have a history of depression? Do you want to lose weight or have a healthier lifestyle? You may be eligible to participate in a research study evaluating a new lifestyle intervention for weight loss. Participants will receive 10 sessions of therapy at no cost to you.

If you are interested in participating or would like additional information, please call Samantha at 617-643-2076.

 

The MGH Center for Women’s Mental Health

Perinatal and Reproductive Psychiatry Program

Simches Research Building

185 Cambridge St Suite 2200

Boston, MA 02114

 

To make an appointment:

Massachusetts General Hospital Clinical Program: (617) 724-7792

Location of appointments: 

Wang Ambulatory Care Center, Massachusetts General Hospital

15 Parkman St., Floor 8

Boston, MA 02114-3117 

Latest News from our Blog

  • Auto-Caesarean Section: A Review of 22 Cases

    October 19, 2017

    An auto-Caesarean sections is a type of self-surgery in which a woman attempts to perform a Caesarean section on herself.  Not only is this practice very rare, but also the cases in which it does occur have  not been studied.  In order to better understand this phenomenon,  Szabo and Brockington conducted a review of the ...

    Read more

  • Maternal Bipolar Disorder Not a Predictor of Infant Developmental Deficits at One Year of Age

    October 18, 2017

      While some women with bipolar disorder elect to discontinue their psychotropic medications during pregnancy to mitigate fetal exposure, Viguera and colleagues (2000, 2007) found that women stabilized on lithium face a significant risk for relapse if they choose to discontinue treatment during pregnancy.  These treatment decisions are difficult and vary on a case-to-case basis, but ...

    Read more

  • In Brief: Folate Supplements During Pregnancy Reduce Risk of Autism  

    October 16, 2017

      Mothers exposed to household or agricultural pesticides immediately before and during their pregnancies have a higher risk of having a child with autism spectrum disorder (ASD).  However, a recent study from California indicates that taking high-dose folic acid cuts this risk in half, as compared to women who received lower doses of folic acid.  In ...

    Read more

  • Weekly Roundup for October 6, 2017: Recent Publications in Women’s Mental Health

    October 6, 2017

    Some interesting articles this week: understanding the impact of anxiety disorders on pregnancy outcomes (Yonkers et al), impact of antenatal exposure to antidepressants during pregnancy on risk of subsequent psychiatric illness in the child (Liu et al), and a look at risk for substance abuse disorders during pregnancy ( Ruta Nonacs, MD PhD Rasmussen MH, Strøm M, ...

    Read more

  • What is the Risk of Postpartum Depression in Women with No Psychiatric History?

    October 4, 2017

    We know that about 15% of women suffer from postpartum depression (PPD).  But what is less clear is how to reliably identify women with PPD and to then ensure that they get the support and treatment they need.  Women with a history of psychiatric illness are often identified as being at higher risk for postpartum ...

    Read more

  • ACOG Releases Revised Guidelines for Treatment of Opioid Use During Pregnancy

    September 26, 2017

    We have been writing over the last few years about the growing problem of opioid use and abuse in women of reproductive age.  Responding to a dramatic increase in the number of women abusing opiates during pregnancy, the American College of Obstetricians and Gynecologists (ACOG) has released revised guidelines on the treatment of opioid use ...

    Read more

Read more from our Blog

Recent Awards

banner_postpartum-depression

Awarded by Healthline.com

Awarded by Feedspot.com

 

 

 

 

 

 

Awarded by Feedspot.com

Awarded by Cables and Sensors